| ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2 (NCT05463289) | Johns Hopkins University | 2022-07-11 |
| Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis (NCT05229640) | Dartmouth-Hitchcock Medical Center | 2022-03-31 |
| Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function (NCT04530383) | University of Kansas Medical Center | 2022-02-14 |
| Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes. (NCT05377502) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-12-15 |
| A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis (NCT04519853) | Boston Children's Hospital | 2021-10-25 |
| Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes (NCT03258853) | Massachusetts General Hospital | 2021-08-26 |
| Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes (NCT04533646) | Jagdeesh Ullal | 2020-09-15 |
| Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes (NCT04381429) | University Hospital, Strasbourg, France | 2020-08-17 |
| β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis (NCT04379726) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2020-07-01 |
| Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management (NCT03939065) | University of Colorado, Denver | 2020-06-12 |
| A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance. (NCT04503408) | Hacettepe University | 2019-09-13 |
| EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis (NCT03650712) | Katie Larson Ode | 2019-07-01 |
| Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis (NCT03961516) | University Hospitals Cleveland Medical Center | 2019-05-01 |
| Measurement of Beta Cell Death in Individuals With Cystic Fibrosis (NCT03713437) | University of Nebraska | 2019-04-04 |
| A CFit Study - Acute Exercise (NCT03237767) | University of Portsmouth | 2018-05-01 |
| A CFit Study - Baseline (NCT03234387) | University of Portsmouth | 2017-11-17 |
| Simplification of CF-related Diabetes Screening at Home (NCT03227094) | Institut de Recherches Cliniques de Montreal | 2017-11-13 |
| Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis. (NCT03205904) | Hospital de Clinicas de Porto Alegre | 2016-12-12 |
| The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis (NCT02810691) | Institut de Recherches Cliniques de Montreal | 2016-07-01 |
| The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes (NCT02703155) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2015-10-01 |
| Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes (NCT02398383) | Yale University | 2015-03-01 |
| Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) (NCT02039986) | Children's Hospital of Philadelphia | 2014-01-06 |
| Effects of an Exercise Program Among CF Patients With Dysglycemia (NCT02127957) | Institut de Recherches Cliniques de Montreal | 2013-07-01 |
| Cystic Fibrosis Related Diabetes Screening. (NCT02723968) | Hospices Civils de Lyon | 2009-09-01 |
| Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD) (NCT00639626) | Nationwide Children's Hospital | 2008-08-01 |
| Genetic Modifiers of Cystic Fibrosis Related Diabetes (NCT01113216) | Johns Hopkins University | 2008-04-01 |
| Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis (NCT00763412) | Arbelaez, Ana Maria | 2006-11-01 |
| Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients. (NCT00287456) | University of Texas Southwestern Medical Center | 2006-02-02 |
| Insulin Glargine Vs Standard Insulin Therapy (NCT00222521) | University of Minnesota | 2003-04-01 |
| The Microvascular Complications Study (NCT00222508) | University of Minnesota | 2001-04-01 |